Fintel reports that on October 22, 2025, D. Boral Capital maintained coverage of Medicus Pharma (NasdaqCM:MDCX) with a Buy recommendation. Analyst Price Forecast Suggests 735.83% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback